Bradley Duffy

Array ( [id] => 6014852 [patent_doc_number] => 20110223168 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'LIGAND THAT HAS BINDING SPECIFICITY FOR IL-4 AND/OR IL-13' [patent_app_type] => utility [patent_app_number] => 13/111516 [patent_app_country] => US [patent_app_date] => 2011-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 56508 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20110223168.pdf [firstpage_image] =>[orig_patent_app_number] => 13111516 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8340329 [patent_doc_number] => 08242252 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-14 [patent_title] => 'CD19 binding agents and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/109957 [patent_app_country] => US [patent_app_date] => 2011-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 61557 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13109957 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8017623 [patent_doc_number] => 08138315 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-20 [patent_title] => 'Anti-alpha V immunoliposome compositions, methods and uses' [patent_app_type] => utility [patent_app_number] => 13/105643 [patent_app_country] => US [patent_app_date] => 2011-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 50 [patent_no_of_words] => 25263 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/138/08138315.pdf [firstpage_image] =>[orig_patent_app_number] => 13105643 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8690165 [patent_doc_number] => 08389692 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-05 [patent_title] => 'Anti-platelet membrane glycoprotein VI monoclonal antibody' [patent_app_type] => utility [patent_app_number] => 13/095098 [patent_app_country] => US [patent_app_date] => 2011-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 47 [patent_no_of_words] => 46912 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13095098 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8689760 [patent_doc_number] => 08389286 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-05 [patent_title] => 'Cancer-associated antigen' [patent_app_type] => utility [patent_app_number] => 13/094118 [patent_app_country] => US [patent_app_date] => 2011-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 21 [patent_no_of_words] => 25226 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13094118 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7566946 [patent_doc_number] => 20110287009 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-24 [patent_title] => 'Production of Heteromultimeric Proteins' [patent_app_type] => utility [patent_app_number] => 13/092708 [patent_app_country] => US [patent_app_date] => 2011-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 49405 [patent_no_of_claims] => 89 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20110287009.pdf [firstpage_image] =>[orig_patent_app_number] => 13092708 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8201562 [patent_doc_number] => 08188239 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-29 [patent_title] => 'Multivalent carriers of bi-specific antibodies' [patent_app_type] => utility [patent_app_number] => 13/089645 [patent_app_country] => US [patent_app_date] => 2011-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 52833 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/188/08188239.pdf [firstpage_image] =>[orig_patent_app_number] => 13089645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10136012 [patent_doc_number] => 09169325 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-27 [patent_title] => 'Antibodies that bind human CD27 and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/086286 [patent_app_country] => US [patent_app_date] => 2011-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 37 [patent_no_of_words] => 36977 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13086286 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7573978 [patent_doc_number] => 20110269634 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'Methods and Compositions for Risk Stratification' [patent_app_type] => utility [patent_app_number] => 13/082306 [patent_app_country] => US [patent_app_date] => 2011-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 42119 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20110269634.pdf [firstpage_image] =>[orig_patent_app_number] => 13082306 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8066175 [patent_doc_number] => 20110243934 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'EPHA3 ANTIBODIES FOR THE TREATMENT OF MULTIPLE MYELOMA' [patent_app_type] => utility [patent_app_number] => 13/078747 [patent_app_country] => US [patent_app_date] => 2011-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14795 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0243/20110243934.pdf [firstpage_image] =>[orig_patent_app_number] => 13078747 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7487446 [patent_doc_number] => 20110236387 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'POLYPEPTIDES AND ANTIBODIES DERIVED FROM CHRONIC LYMPHOCYTIC LEUKEMIA CELLS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/072470 [patent_app_country] => US [patent_app_date] => 2011-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 55 [patent_no_of_words] => 24183 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20110236387.pdf [firstpage_image] =>[orig_patent_app_number] => 13072470 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10870515 [patent_doc_number] => 08895714 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-25 [patent_title] => 'Biological products' [patent_app_type] => utility [patent_app_number] => 13/049087 [patent_app_country] => US [patent_app_date] => 2011-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 15 [patent_no_of_words] => 9423 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13049087 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8214616 [patent_doc_number] => 08193313 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-05 [patent_title] => 'Methods and compositions for tumor vaccination and therapy' [patent_app_type] => utility [patent_app_number] => 13/046875 [patent_app_country] => US [patent_app_date] => 2011-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 21 [patent_no_of_words] => 24008 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/193/08193313.pdf [firstpage_image] =>[orig_patent_app_number] => 13046875 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7510010 [patent_doc_number] => 20110256153 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'CD37-Binding Molecules and Immunoconjugates Thereof' [patent_app_type] => utility [patent_app_number] => 13/045693 [patent_app_country] => US [patent_app_date] => 2011-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 44432 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 44 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20110256153.pdf [firstpage_image] =>[orig_patent_app_number] => 13045693 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10063897 [patent_doc_number] => 09102728 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-11 [patent_title] => 'PD-1 antibodies' [patent_app_type] => utility [patent_app_number] => 13/045718 [patent_app_country] => US [patent_app_date] => 2011-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 46 [patent_no_of_words] => 20396 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13045718 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9026309 [patent_doc_number] => 08535890 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-17 [patent_title] => 'Methods to determine immunogenicity of humanized anti-tag 72 CC49 antibodies' [patent_app_type] => utility [patent_app_number] => 13/039171 [patent_app_country] => US [patent_app_date] => 2011-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 18589 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 237 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13039171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11408988 [patent_doc_number] => 09556279 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-01-31 [patent_title] => 'Antibody variants composition' [patent_app_type] => utility [patent_app_number] => 13/038576 [patent_app_country] => US [patent_app_date] => 2011-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 38236 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13038576 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6046671 [patent_doc_number] => 20110206672 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => 'Antigen-Binding Molecule And Uses Thereof' [patent_app_type] => utility [patent_app_number] => 13/034920 [patent_app_country] => US [patent_app_date] => 2011-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13477 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0206/20110206672.pdf [firstpage_image] =>[orig_patent_app_number] => 13034920 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5935943 [patent_doc_number] => 20110212088 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'ANTI-PAF ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 13/035821 [patent_app_country] => US [patent_app_date] => 2011-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 27348 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20110212088.pdf [firstpage_image] =>[orig_patent_app_number] => 13035821 [rel_patent_id] =>[rel_patent_doc_number] =>)